IRIS
ANGELUCCI, ADRIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.153
EU - Europa 3.273
AS - Asia 1.735
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
OC - Oceania 7
Totale 10.185
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.136
IE - Irlanda 1.003
CN - Cina 783
DE - Germania 519
TR - Turchia 492
SE - Svezia 471
SG - Singapore 395
IT - Italia 336
UA - Ucraina 276
GB - Regno Unito 271
FI - Finlandia 155
FR - Francia 131
CZ - Repubblica Ceca 35
BE - Belgio 30
IN - India 20
CA - Canada 15
NL - Olanda 10
EU - Europa 9
KR - Corea 9
VN - Vietnam 8
BR - Brasile 6
TW - Taiwan 6
ES - Italia 5
AU - Australia 4
HK - Hong Kong 4
RU - Federazione Russa 4
AT - Austria 3
CH - Svizzera 3
HU - Ungheria 3
IL - Israele 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
DK - Danimarca 2
JP - Giappone 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CR - Costa Rica 1
GR - Grecia 1
IR - Iran 1
IS - Islanda 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 10.185
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.102
Chandler 1.022
Dublin 1.000
Boardman 391
Singapore 334
Santa Clara 327
Izmir 257
Nanjing 228
San Mateo 200
Wilmington 165
Lawrence 145
Princeton 145
New York 139
Ann Arbor 127
Bremen 117
Ashburn 99
L'aquila 89
Munich 71
Beijing 63
Milan 61
Nanchang 61
Woodbridge 61
Seattle 60
Shenyang 53
Mountain View 49
Des Moines 40
Hebei 39
Jiaxing 39
Verona 35
Brno 32
Helsinki 31
Shanghai 31
Tianjin 30
Brussels 29
Strasbourg 28
Kunming 27
Zhengzhou 23
Changsha 21
Falls Church 21
Torre Del Greco 20
Jinan 19
Ningbo 19
Dearborn 18
Los Angeles 17
Norwalk 17
Philadelphia 16
Dallas 14
Guangzhou 14
Hangzhou 13
L’Aquila 13
Taizhou 12
Pune 11
Lanzhou 10
Düsseldorf 9
Tappahannock 9
Aquila 8
Dong Ket 8
Grafing 8
Rome 8
Fremont 7
Belfast 6
Houston 6
Little Rock 6
Nuremberg 6
Pescara 6
Auburn Hills 5
Berlin 5
Cagliari 5
San Francisco 5
Edinburgh 4
Kitzingen 4
Ottawa 4
Redwood City 4
Toronto 4
Wuhan 4
Auckland 3
Budapest 3
Cedar Knolls 3
Changchun 3
Delhi 3
Domodossola 3
Frankfurt am Main 3
Harbin 3
Hong Kong 3
Miglianico 3
Washington 3
Amsterdam 2
Bandar Seri Begawan 2
Bologna 2
Chongqing 2
Copenhagen 2
Fuzhou 2
Hanover 2
Islamabad 2
Kuala Lumpur 2
Lima 2
Lombard 2
London 2
Lugones 2
Madrid 2
Totale 7.197
Salva come PNG Salva come JPEG
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 110
Serum 25(OH)D seasonality in urologic patients from central Italy 108
Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion 101
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma 100
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 98
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 98
Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disaster 97
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 93
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer 93
Obesity in the elderly - On the role of adipokines in prostate cancer progression 89
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 89
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 84
Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant 83
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 83
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 82
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 82
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 82
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 81
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 81
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells 81
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 81
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 81
Apoptosis or programmed cell death 80
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 80
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 80
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 80
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 80
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 79
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 79
INIBITORI DI METALLOPROTEASI DI MATRICE: PROSPETTIVE TERAPEUTICHE. EOS - JOURNAL OF IMMUNOLOGY AND IMMUNOPHARMACOLOGY, VOL.XXI – 2001 – N.1: 22-27 78
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 78
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 78
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 78
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation 78
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 77
Introductory Immunology 77
Therapeutic potential of Askina® Gel in regenerative medicine 77
Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesis. 77
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors 76
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 76
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 76
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 76
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 76
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 76
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 76
Non-conventional role of haemoglobin beta in breast malignancy 76
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 75
Targeting ERBB receptors to inhibit metastasis: old hopes and new certainties 75
Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors 75
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells 75
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 74
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones 74
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 74
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 73
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-D] PYRIMIDINE AND PYRROLO [2,3-D] PYRIMIDINE AND USES THEREOF 73
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 73
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 73
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering 73
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 72
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors 71
Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs) 71
Apoptosi e sistema immunitario: regolazione e patologie associate 70
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 69
Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism 69
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 69
Inhibition of tyrosine kinase c-Src improves experimental breast cancer metastatic disease. Implication for therapy 69
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 68
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 68
Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer 68
LA VALUTAZIONE DELL’ATTIVITA’ TELOMERASICA SU MASSAGGIO PROSTATICO PERMETTE DI MIGLIORARE LA DIFFERENZIAZIONE TRA LA PATOLOGIA TUMORALE PROSTATICA E L’IPERPLASIA PROSTATICA BENIGNA 68
Pro-angiogenic potential of adipose derived mesenchimal stem cells (AD-MSCs) in hypoxic condition 68
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice 68
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 68
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 67
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 67
Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cells 67
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 67
Therapeutic potential of a biomatrix (Askina gel) in regenerative medicine 67
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells 67
Plasma brain-derived neurotrophic factor in earthquake survivors with full and partial post-traumatic stress disorder 67
Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond 66
Src family kinases as therapeutic targets in advanced solid tumors: What we have learned so far 66
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 65
A set of genes expressed in breast cancer bone metastases discloses predisposition to generate metastases in multiple organs 65
Trattamento con casodex ed iressa nel tumore della prostata: evidenze biologiche a favore. 65
Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines 64
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 64
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells 64
NEUROENDOCRINE TRANSDIFFERENTIATION INDUCED BY HDAC INHIBITORS CONFERS RESISTANCE TO ANTIBLASTIC THERAPY IN PROSTATE CARCINOMA 64
Possibile anti-apoptotic activity of carnitines on excitatory amino acid induced neurotoxicity 64
New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells 64
Mechanisms underlying the anti-tumoral effects of Citrus Bergamia juice 63
Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia 63
LA TERAPIA ANTIANDROGENICA FAVORISCE L’INSORGENZA DELL’ANDROGENO INDIPENDENZA AUMEN-TANDO L’ESPRESSIONE DEL RECETTORE PER IL FATTORE DI CRESCITA EPIDERICO 63
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells 63
Reduction of glutamate levels in HIV-infected subjects treated with acetylcarnitine 62
Verso una teoria ecologica dei tumori 61
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 61
Fenomeni adattativi dopo terapia antiandrogenica nel tumore della prostata 61
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 61
Totale 7.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020582 0 0 0 0 0 0 210 11 153 31 11 166
2020/20211.231 27 143 4 149 149 52 160 11 161 59 255 61
2021/2022980 63 88 183 66 43 23 15 52 48 33 82 284
2022/20233.005 198 157 57 314 346 321 3 214 1.238 19 90 48
2023/2024728 99 45 40 126 53 215 12 37 2 17 20 62
2024/20251.117 74 74 233 112 373 251 0 0 0 0 0 0
Totale 10.295